Medibank Private (MPL) is a AU-listed Financial Services company in Medical - Healthcare Plans with a market capitalization of A
4.1B, trading at A$5.11 on the ASX. This SniperIQ fundamentals page covers Medibank Private's valuation (P/E 30.4x, P/B 6.0x), profitability (net margin 5.3%), revenue (A$8.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market CapA
4.1B
P/E (TTM)30.4x
Net Margin5.3%
Revenue (FY25)A$8.6B
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is Medibank Private's market cap?
Medibank Private (MPL) has a market capitalization of approximately A
4.1B, trading at A$5.11 on the ASX. Market cap moves with the live share price.
What is Medibank Private's P/E ratio?
Medibank Private's trailing twelve-month P/E ratio is 30.4x, with a price-to-book (P/B) of 6.0x. Valuation multiples are best compared with Financial Services sector peers rather than read in isolation.
How profitable is Medibank Private?
Medibank Private runs a net profit margin of 5.3%, a gross margin of 100.0%, and an operating margin of 48.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Medibank Private generate?
Medibank Private reported revenue of A$8.6B for fiscal year 2025, with net income of A$501M and earnings per share (EPS) of 0.18. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Medibank Private pay a dividend?
Medibank Private offers a trailing dividend yield of about 3.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Medibank Private financially healthy?
Medibank Private carries a debt-to-equity ratio of 0.21x and a current ratio of 13.45x, with a market beta of 0.05. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Medibank Private a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Medibank Private (MPL) the key facts are: market cap A
4.1B, P/E 30.4x, revenue A$8.6B, 52-week range 4.06-5.28. Weigh valuation, profitability, growth, and balance-sheet strength against Financial Services peers and form your own view.
Track Medibank Private's full fundamentals live
Get Medibank Private's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.